[Re-operative Cardiac Surgery in Patients with Patent In Situ Coronary Artery Bypass Grafts]

Yasuhisa Fukada1, Yoshiki Endo, Akinobu Kitagawa

  • 1Department of Cardiovascular Surgery, Iwaki City Medical Center, Iwaki, Japan.

Insights

A simplified approach to myocardial protection during redo cardiac surgery in patients with prior coronary artery bypass grafting (CABG) involving no in situ graft clamping is safe and effective. This technique avoids graft injury and ensures adequate cardiac protection.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Anesthesia
  • Thoracic Surgery

Background:

  • Re-operative cardiac surgery following coronary artery bypass grafting (CABG) presents significant challenges, particularly concerning in situ graft integrity and myocardial protection.
  • Conventional methods involve dissecting and clamping in situ grafts, increasing the risk of catastrophic complications due to graft injury.

Purpose of the Study:

  • To evaluate the safety and effectiveness of a simplified myocardial protection strategy in redo CABG patients with patent in situ grafts.
  • To compare outcomes between a technique involving in situ graft clamping and one that avoids it.

Main Methods:

  • A retrospective review of 25 redo CABG cases with patent in situ grafts was conducted.
  • Patients were divided into two groups: Group C (18 patients) underwent in situ graft dissection and clamping, while Group U (7 patients) did not.
  • Both groups received moderate hypothermia and cardioplegia for myocardial protection during aortic cross-clamping.

Main Results:

  • No instances of in situ graft injury were observed in either group.
  • Peak creatine kinase-MB levels, a marker of myocardial injury, showed no significant difference between the groups.
  • Postoperative ejection fraction was preserved in all patients, indicating maintained cardiac function.

Conclusions:

  • The simplified no-clamping technique offers a safe and effective alternative for myocardial protection in redo CABG patients with patent in situ grafts.
  • This approach mitigates the risks associated with conventional graft manipulation, simplifying the procedure.
Abstract